Stay updated on Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial
Sign up to get notified when there's something new on the Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial page.

Latest updates to the Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial page
- Check3 days agoChange DetectedOsteoarthritis and MedlinePlus Genetics related topics were removed from the page's related topics section. Removing Osteoarthritis reduces context and discoverability for OA-related searches, while removing MedlinePlus Genetics decreases cross-references to genetic resources for this study.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the revision history.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded Osteoarthritis as a related topic and MedlinePlus Genetics as a related topic.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded Revision: v3.4.2; removed Osteoarthritis, related topics, MedlinePlus Genetics, and Revision: v3.4.1.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision history shows an update from v3.4.0 to v3.4.1. No user-visible changes to study details, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedGlossary display option added and QC/policy metadata updated to show 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with 'Revision: v3.4.0', replacing the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.1%

Stay in the know with updates to Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial page.